These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31298317)

  • 1. MicroRNA-93-5p/IFNAR1 axis accelerates metastasis of endometrial carcinoma by activating the STAT3 pathway.
    Xu JB
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5657-5666. PubMed ID: 31298317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.
    Ma DH; Li BS; Liu JJ; Xiao YF; Yong X; Wang SM; Wu YY; Zhu HB; Wang DX; Yang SM
    Cancer Lett; 2017 Nov; 408():23-32. PubMed ID: 28842285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells.
    Bao W; Wang HH; Tian FJ; He XY; Qiu MT; Wang JY; Zhang HJ; Wang LH; Wan XP
    Mol Cancer; 2013 Dec; 12():155. PubMed ID: 24321270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-487a promotes proliferation of esophageal cancer cells by inhibiting p62 expression.
    Ma JB; Hu SL; Zang RK; Su Y; Liang YC; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1502-1512. PubMed ID: 30840272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
    Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1.
    He CL; Liu M; Tan ZX; Hu YJ; Zhang QY; Kuang XM; Kong WL; Mao Q
    World J Gastroenterol; 2018 Jan; 24(2):226-236. PubMed ID: 29375208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
    Wang Y; Dong L; Liu Y
    Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
    [No Abstract]   [Full Text] [Related]  

  • 9. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
    Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-409 down-regulates Jak-Stat pathway to inhibit progression of liver cancer.
    Zhang CS; Lin Y; Sun FB; Gao J; Han B; Li SJ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):146-154. PubMed ID: 30657556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
    Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway.
    Fan JT; Zhou ZY; Luo YL; Luo Q; Chen SB; Zhao JC; Chen QR
    Neoplasia; 2021 Jul; 23(7):692-703. PubMed ID: 34153644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
    Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
    J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p.
    Zhu L; Liu Y; Yang Y; Mao XM; Yin ZD
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2817-2826. PubMed ID: 31002133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro-RNA signature of lymphovascular space involvement in type 1 endometrial cancer.
    Canlorbe G; Castela M; Bendifallah S; Wang Z; Lefevre M; Chabbert-Buffet N; Aractingi S; DaraÏ E; Méhats C; Ballester M
    Histol Histopathol; 2017 Sep; 32(9):941-950. PubMed ID: 28000202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.
    Tian ZG; Zhuang Y; Jin Z; Zhou F; Zhu LF; Shen PC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5460-5470. PubMed ID: 30229817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-130b-5p accelerates the migration and invasion of osteosarcoma via binding to TIMP2.
    Cheng ZH; Luo C; Guo ZL
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9267-9276. PubMed ID: 31773678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM4 is targeted by miR-449b-5p to promote the proliferation of endometrial carcinoma.
    Zhao J; Dong X; Tao SJ; Liu XL; Li Z; Liu JM; Chen Y
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11528-11535. PubMed ID: 33275219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.